<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3 - Final Filing)
PHARMAKINETICS LABORATORIES, INC.
---------------------
(Name of Issuer)
Common Stock, par value, $.001 per share
----------------------------------------------------
(Title of Class of Securities)
717131106
------------------------
(CUSIP Number)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6 Pages
<PAGE>
<PAGE> SCHEDULE 13G
- ------------------- -----------------
CUSIP No. 717131106 Page 2 of 6 Pages
- ------------------- ------------------
===========================================
======================
1 NAME OF REPORTING PERSON - S.S. OR I.R.S. IDENTIFICATION NO. OF
ABOVE PERSON
Allen Holding Inc.
- -----------------------------------------------------------------
1 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ]
(b)[x]
- -----------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -----------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH
- -----------------------------------------------------------------
5 SOLE VOTING POWER
0
- -----------------------------------------------------------------
6 SHARED VOTING POWER
0
- -----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
- -----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- -----------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
0
- -----------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [x]
- -----------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.19%
- -----------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
HC
===========================================
======================
<PAGE>
<PAGE> SCHEDULE 13G
- ------------------- -----------------
CUSIP No. 717131106 Page 3 of 6 Pages
- ------------------- -----------------
===========================================
======================
1 NAME OF REPORTING PERSON - S.S. OR I.R.S. IDENTIFICATION NO. OF
ABOVE PERSON
Allen & Company Incorporated
- -----------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [x]
- -----------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
- -----------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH
- -----------------------------------------------------------------
5 SOLE VOTING POWER
Not Applicable
- -----------------------------------------------------------------
6 SHARED VOTING POWER
0
- ----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
Not Applicable
- -----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- -----------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
Not Applicable
- -----------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
- -----------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.19%
- -----------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
BD; CO
===========================================
======================
<PAGE>
<PAGE> Page 4 of 6 Pages
SCHEDULE 13G
Item 1.
(a) Name of Issuer:
Pharmakinetics Laboratories, Inc.
(b) Address of Issuer's Principal Executive Office:
302 West Fayette Street
Baltimore, Maryland 21201
Item 2. Name of Person Filing
(a) Name of Person Filing:
Allen & Company Incorporated ("ACI")
Allen Holding Inc.("AHI")
(b) Address of Principal Office:
711 Fifth Avenue
New York, New York 10022
(c) Citizenship/Organization:
ACI - New York
AHI - Delaware
(d) Title Class of Securities:
Common Stock, par value $.001 per share
(e) CUSIP Number: 71731106
Item 3. If Statement is filed pursuant to Rules 13(d)-1(b) or13d-2(b), check
whether Person Filing is a
(a) [X] ACI is a Broker-Dealer registered under Section 15 of
the Act.
(g) [X] AHI is a parent holding company in accordance with
Rule 13d-1(b)(ii)(G).
<PAGE>
<PAGE> Page 5 of 6 Pages
Item 4. Ownership.
(a) Amount Beneficially Owned:
Not Applicable
(b) Percent of Class: 4.19%
(c) Number of Shares to Which Such Person Has:
(i) Sole voting power - Not Applicable
(ii) Shared voting power - 0
(iii) Sole dispositive power - Not Applicable
(iv) Shared dispositive power - 0
Item 5. Ownership of Five Percent or Less of a Class.
ACI ceased to be the beneficial owner of five percentor more of the
Issuer's Common Stock. This Amendment No. 3 is therefore a final filing.
Item 6. Ownership of More Than Five Percent on Behalf ofAnother Person.
Not Applicable.
Item 7. Identification and Classification of Members of theSubsidiary
Which Acquired the Securities Being Reported on by the Parent
Holding Company.
Not Applicable.
Item 8. Identification and Classification of Members of theGroup.
Not Applicable.
Item 9. Notice of Dissolution of Group.
Not Applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
<PAGE>
<PAGE> Page 6 of 6 Pages
Signature: After reasonable inquiry and to the best of our knowledge and
belief, we certify that the information set forth in this statement is true,
complete and correct.
Date: February 11, 1999
ALLEN & COMPANY INCORPORATED
By:---------------------------
Name: Gaetano J. Casillo
Title: Vice President
ALLEN HOLDING INC.
By:---------------------------
Name: Gaetano J. Casillo
Title: Vice President
134478
<PAGE>
<PAGE> Page 6 of 6 Pages
Signature: After reasonable inquiry and to the best of our knowledge and
belief, we certify that the information set forth in this statement is true,
complete and correct.
Date: February 11, 1999
ALLEN & COMPANY INCORPORATED
/x/ Gaetano J. Casillo
By:-----------------------------
Name: Gaetano J. Casillo
Title: Vice President
ALLEN HOLDING INC.
/x/ Gaetano J. Casillo
By:----------------------------
Name: Gaetano J. Casillo
Title: Vice President
134478
*** Conversion terminated at this point (TRIAL version of software).
